Tanseli Nesil1, Syeda Narmeen1, Anousheh Bakhti-Suroosh1, Wendy J Lynch2,3. 1. Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, 22902, USA. 2. Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, 22902, USA. wlynch@virginia.edu. 3. Department of Psychiatry and Neurobehavioral Sciences, PO Box 801402, Charlottesville, VA, 22904, USA. wlynch@virginia.edu.
Abstract
RATIONALE: Epidemiological data suggest that menthol may increase vulnerability to cigarette/nicotine use and relapse. While menthol's sensory properties are often attributed as the underlying cause of the enhanced vulnerability, an alternative possibility is that they are mediated via pharmacological interactions with nicotine. OBJECTIVE: This study addressed the possibility that menthol enhances nicotine intake and relapse vulnerability via pharmacological interactions with nicotine using a concurrent intravenous menthol/nicotine self-administration procedure. METHODS: Following acquisition, adolescent rats were given 23-h/day access to nicotine (0.01 mg/kg/infusion), nicotine plus menthol (0.16, 0.32, or 0.64 mg/kg/infusion), or menthol alone (0.16, 0.32, 0.64 mg/kg/infusion) for a total of 10 days. Nicotine-seeking was assessed using an extinction/cue-induced reinstatement procedure following 10 days of forced abstinence. We also assessed the effect of menthol (0.32 mg/kg/infusion) on progressive ratio responding for nicotine (0.01 mg/kg/infusion). RESULTS: Menthol decreased PR responding for nicotine but did not affect self-administration under extended access conditions. The low dose of menthol tended to decrease subsequent extinction responding, and was not different from menthol alone, whereas the high dose decreased reinstatement responding. Although not significant, the highest levels of extinction responding were observed in a minority of rats in the moderate and high menthol-nicotine groups; rats in these groups also took longer to extinguish. CONCLUSIONS: Taken together, these results demonstrate that pharmacological interactions of menthol with nicotine reduce, rather than increase, nicotine's reinforcing effects and some measures of relapse vulnerability. Importantly, however, moderate and high menthol doses may increase some aspects of relapse vulnerability in a minority of individuals.
RATIONALE: Epidemiological data suggest that menthol may increase vulnerability to cigarette/nicotine use and relapse. While menthol's sensory properties are often attributed as the underlying cause of the enhanced vulnerability, an alternative possibility is that they are mediated via pharmacological interactions with nicotine. OBJECTIVE: This study addressed the possibility that menthol enhances nicotine intake and relapse vulnerability via pharmacological interactions with nicotine using a concurrent intravenous menthol/nicotine self-administration procedure. METHODS: Following acquisition, adolescent rats were given 23-h/day access to nicotine (0.01 mg/kg/infusion), nicotine plus menthol (0.16, 0.32, or 0.64 mg/kg/infusion), or menthol alone (0.16, 0.32, 0.64 mg/kg/infusion) for a total of 10 days. Nicotine-seeking was assessed using an extinction/cue-induced reinstatement procedure following 10 days of forced abstinence. We also assessed the effect of menthol (0.32 mg/kg/infusion) on progressive ratio responding for nicotine (0.01 mg/kg/infusion). RESULTS:Menthol decreased PR responding for nicotine but did not affect self-administration under extended access conditions. The low dose of menthol tended to decrease subsequent extinction responding, and was not different from menthol alone, whereas the high dose decreased reinstatement responding. Although not significant, the highest levels of extinction responding were observed in a minority of rats in the moderate and high menthol-nicotine groups; rats in these groups also took longer to extinguish. CONCLUSIONS: Taken together, these results demonstrate that pharmacological interactions of menthol with nicotine reduce, rather than increase, nicotine's reinforcing effects and some measures of relapse vulnerability. Importantly, however, moderate and high menthol doses may increase some aspects of relapse vulnerability in a minority of individuals.
Authors: Jiu Ai; Kenneth M Taylor; Joseph G Lisko; Hang Tran; Clifford H Watson; Matthew R Holman Journal: Tob Control Date: 2017-06-30 Impact factor: 7.552
Authors: Robert J Wickham; Eric J Nunes; Shannon Hughley; Phillip Silva; Sofia N Walton; Jinwoo Park; Nii A Addy Journal: Neuropharmacology Date: 2017-09-21 Impact factor: 5.250
Authors: Y Wendy Huynh; Anthony Raimondi; Andrew Finkner; Jordan D Kuck; Carly Selleck; Rick A Bevins Journal: Psychopharmacology (Berl) Date: 2020-05-24 Impact factor: 4.530
Authors: Anne Havermans; Nadja Mallock; Efthimios Zervas; Stéphanie Caillé-Garnier; Thibault Mansuy; Cécile Michel; Jeroen L A Pennings; Thomas Schulz; Per E Schwarze; Renata Solimini; Jean-Pol Tassin; Constantine I Vardavas; Miguel Merino; Charlotte G G M Pauwels; Lotte E van Nierop; Claude Lambré; Anette K Bolling Journal: Tob Prev Cessat Date: 2022-07-05
Authors: Natalie L Johnson; Theresa Patten; Minghong Ma; Mariella De Biasi; Daniel W Wesson Journal: Front Neurosci Date: 2022-07-19 Impact factor: 5.152